Published 2023 | Version v1
Journal article

Unsupervised learning to characterize patients with known coronary artery disease undergoing myocardial perfusion imaging

  • 1. British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh (United Kingdom)
  • 2. Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, 90048, Los Angeles, CA (United States)
  • 3. Department of Cardiac Sciences, University of Calgary, Calgary, AB (Canada)
  • 4. Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw (Poland)
  • 5. Department of Nuclear Cardiology, Assuta Medical Centers, Tel Aviv, and Ben Gurion University of the Negev, Beer Sheba (Israel)
  • 6. Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, MA (United States)
  • 7. Division of Cardiology, Department of Medicine, and Department of Radiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY (United States)
  • 8. Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (United States)
  • 9. Cardiovascular Imaging Technologies LLC, Kansas City, MO (United States)
  • 10. Oregon Heart and Vascular Institute, Sacred Heart Medical Center, Springfield, OR (United States)
  • 11. Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON (Canada)
  • 12. Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples (Italy)
  • 13. Department of Nuclear Cardiology, Oklahoma Heart Hospital, Oklahoma City, OK (United States)
  • 14. Department of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Zurich (Switzerland)

Description

Patients with known coronary artery disease (CAD) comprise a heterogenous population with varied clinical and imaging characteristics. Unsupervised machine learning can identify new risk phenotypes in an unbiased fashion. We use cluster analysis to risk-stratify patients with known CAD undergoing single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). From 37,298 patients in the REFINE SPECT registry, we identified 9221 patients with known coronary artery disease. Unsupervised machine learning was performed using clinical (23), acquisition (17), and image analysis (24) parameters from 4774 patients (internal cohort) and validated with 4447 patients (external cohort). Risk stratification for all-cause mortality was compared to stress total perfusion deficit (< 5%, 5-10%, ≥10%). Three clusters were identified, with patients in Cluster 3 having a higher body mass index, more diabetes mellitus and hypertension, and less likely to be male, have dyslipidemia, or undergo exercise stress imaging (p < 0.001 for all). In the external cohort, during median follow-up of 2.6 [0.14, 3.3] years, all-cause mortality occurred in 312 patients (7%). Cluster analysis provided better risk stratification for all-cause mortality (Cluster 3: hazard ratio (HR) 5.9, 95% confidence interval (CI) 4.0, 8.6, p < 0.001; Cluster 2: HR 3.3, 95% CI 2.5, 4.5, p < 0.001; Cluster 1, reference) compared to stress total perfusion deficit (≥10%: HR 1.9, 95% CI 1.5, 2.5 p < 0.001; < 5%: reference). Our unsupervised cluster analysis in patients with known CAD undergoing SPECT MPI identified three distinct phenotypic clusters and predicted all-cause mortality better than ischemia alone.

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00259-023-06218-z

Additional details

Identifiers

Publishing Information

Journal Title
European Journal of Nuclear Medicine and Molecular Imaging
Journal Volume
50
Journal Issue
9
Journal Page Range
p. 2656-2668
ISSN
1619-7070
CODEN
EJNMA6

Optional Information

Notes
Oncology #En Dash# General